Epinephrine Autoinjector Market

Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-LACK-sis). Epinephrine comes in the form of easy-to-use auto-injectors. It is only available through a prescription by doctors. Each prescription comes with two auto-injectors in a set.

Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.
Epinephrine Autoinjector Market contains market size and forecasts of Epinephrine Autoinjector in global, including the following market information:
Global Epinephrine Autoinjector Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Epinephrine Autoinjector Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Epinephrine Autoinjector companies in 2021 (%)
The global Epinephrine Autoinjector market was valued at 2223.6 million in 2021 and is projected to reach US$ 3500.8 million by 2028, at a CAGR of 6.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.30 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epinephrine Autoinjector include Mylan, Sanofi, ALK Abello and Impax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epinephrine Autoinjector manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epinephrine Autoinjector Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Autoinjector Market Segment Percentages, by Type, 2021 (%)
0.30 mg
0.15 mg
Global Epinephrine Autoinjector Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Autoinjector Market Segment Percentages, by Application, 2021 (%)
Under 6 Years
6 to 12 Years
Over 12 Years
Global Epinephrine Autoinjector Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Autoinjector Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epinephrine Autoinjector revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Epinephrine Autoinjector revenues share in global market, 2021 (%)
Key companies Epinephrine Autoinjector sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Epinephrine Autoinjector sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Sanofi
ALK Abello
Impax